Brief: Pfizer Says EC Authorizes Update To Pediatric Use Of Pfizer & BioNTech Covid 19 Vaccine
29/05/2026 16:50
BRIEF-Pfizer Says EC Authorizes Update To Pediatric Use Of Pfizer & BioNTech Covid 19 Vaccine May 29 (Reuters) - Pfizer Inc PFE.N:
PFIZER: EUROPEAN COMMISSION AUTHORIZES UPDATE TO PEDIATRIC USE OF PFIZER AND BIONTECH COVID 19 VACCINE
PFIZER - WITH AUTHORIZATION, PFIZER-BIONTECH COVID-19 VACCINE WILL BE ADMINISTERED AS A 10-ΜG DOSE FOR ALL CHILDREN AGED 6 MONTHS THROUGH 11 YEARS
PFIZER: UPDATED MARKETING AUTHORIZATION IS VALID IN ALL 27 EU MEMBER STATES, AS WELL AS ICELAND, LIECHTENSTEIN, AND NORWAY
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pfizer
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials